DNTH EBITDA Growth
Dianthus Therapeutics Inc · EBITDA Growth
DNTH EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported74.17%period ending
DNTH TTM EBITDA YoY % (-61.30% → 74.17%)
Year-over-year change
High-resolution chart · PNG
DNTH ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 74.1708% | |
| 89.0801% | |
| 100.5062% | |
| -88.9371% | |
| -102.9215% | |
| -93.5468% | |
| -87.131% | |
| -48.8067% | |
| -53.8447% | |
| -30.4509% | |
| 17.0214% | |
| 29.0633% | |
| 50.1518% | |
| 46.2047% | |
| 21.2122% | |
| 7.1834% | |
| -7.5337% | |
| -4.8059% | |
| 5.266% | |
| 12.8208% | |
| 16.0286% | |
| 11.9676% | |
| 2.6266% | |
| -13.9326% | |
| -27.5391% | |
| -33.3061% | |
| -32.2846% | |
| -42.0242% | |
| -62.6708% | |
| -45.1887% | |
| -61.2986% |